DX-4012

N/A

Report date: 2025/01/15 20:00:32

Base Information

Drug NameDX-4012

Drug Alias NameDX-4012

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionCoagulation factor XII inhibitors

TargetsCoagulation factor XII

Therapy Area/IndicationsThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDyax Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShire

Active IndicationsN/A

Inactive IndicationsThrombosis

Other Information

ATC CodeN/A